Home › Ulcerative Colitis › Pennsylvania
Pag-aaral pangklinika para sa Ulcerative Colitis sa Pennsylvania
13 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.
Mga Lungsod sa Pennsylvania
Opisyal na teksto ng pag-aaral (English)
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- at 1 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- The Children's Hospital of Philadelphia /ID# 273222, Philadelphia
- Upmc Children'S Hospital Of Pittsburgh /ID# 272328, Pittsburgh
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07071519A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Allegheny Health Network, Wexford
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Penn State Milton S. Hershey Medical Center - Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine - Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health - Site Number: 8400107, Pittsburgh
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07184996Inflammatory Bowel Disease (IBD) Research Registry
- University of Pittsburgh Medical Center, Pittsburgh
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT04243525BOOM-IBD2 Pivotal Clinical Trial
- Pennsylvania Hospital, Philadelphia
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06571669A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400013, Harrisburg
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06975722Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07223424Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Allegheny Health, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT05987852Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.